Status:
UNKNOWN
Long-term Evaluation of Patients Receiving Bone Marrow-derived Cell Administration for Heart Disease
Lead Sponsor:
Johann Wolfgang Goethe University Hospital
Conditions:
Acute Myocardial Infarction
Ischemic Cardiomyopathy
Eligibility:
All Genders
18+ years
Brief Summary
This study will provide follow-up information and care of patients who have undergone autologous intracoronary bone marrow cell administration at our institution. Patients are monitored for their resp...
Detailed Description
In detail, the following procedures are performed during the clinical visits and, if necessary, at additional contacts: * periodic physical examination and blood tests * non-invasive imaging studies ...
Eligibility Criteria
Inclusion
- Clinical diagnosis of heart disease with signs and symptoms of heart failure due to
- acute myocardial infarction or
- ischemic cardiomyopathy with or without previous myocardial infarction or
- dilated cardiomyopathy due to valvular heart disease, hypertensive heart disease, history of myocarditis (no active myocardial infection present)
Exclusion
- none, all patients meeting the inclusion criteria will be eligible.
Key Trial Info
Start Date :
October 1 2001
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2021
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT00962364
Start Date
October 1 2001
End Date
December 1 2021
Last Update
February 26 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cardiology, Department of Internal Medicine III
Frankfurt, Germany, 60590